All News

Immunotherapy agents are drastically changing the treatment landscape – and outcomes – of patients with head and neck cancers.

Andrew D. Zelenetz, M.D., Ph.D. weighs in on recent research and the future of treating hematologic malignancies.

Stivarga was granted a priority review by the FDA to treat certain patients with liver cancer in the second line setting.

Patients with cancer who have Medicare health insurance spend a high percentage of their annual income on out-of-pocket medical costs, a recent study found.

Feeding people is hard, and doing it

Two-time cancer survivor shares effective, yet gentle ways to change habits for the new year.

NATRELLE INSPIRA ® SoftTouch breast implants were recently approved for women with breast cancer.

Over-the-counter pain management drugs may negatively affect the outcomes of patients with endometrial cancer, a recent study found.

Expedited surgery for patients who are recently diagnosed with endometrial cancer may actually lead to increased mortality, according to a recent study.

Exercise had become a way of life for this metastatic breast cancer patient, but the Livestrong program at the YMCA provided the chance to add more variety into her routine and, more importantly, offered the chance to see the strength and hope in fellow survivors.

Becoming comfortable and complacent in the world of breast cancer is an easy thing to do, and learning to thrive can be a challenge.

It is important that caregivers for patients with lung cancer take care of themselves and ask for help when needed. This will ultimately make them better able to care for their loved ones.

Adding Xtandi to Zytiga and prednisone did not improve progression-free survival for patients with metastatic castration-resistant prostate cancer, according to a recent study.

Liquid biopsies are quick, convenient and a crucial part of planning treatment for many patients with lung cancer, says Luis E. Raez, M.D.

The PD-L1 inhibitor durvalumab was granted a priority review for the treatment of some patients with urothelial carcinoma.

Novel combinations may lead to the future of HR+ breast cancer care.

The antibiotic used to treat C. diff in patients with blood cancer who are undergoing bone marrow transplantation, may actually prevent the infection before it happens, according to a recent study.

Immunotherapy may be a promising option for patients with osteosarcoma, Nancy Gordon, M.D., says.

Even the strictest of eating routines deserve occasional exceptions.

Overall, melanoma incidences increased over the past year in the United States, but deaths did not, according to a recent study which stratified the data by state.

There were many personal ups and downs, as well as newsworthy cancer advancements in the year 2016. CURE covered them all. Check out our top stories from the year.

Computed-tomography (CT)-planned high-dose-rate (HDR) intracavitary brachytherapy (BT) showed excellent local control for patients with stage 1 or 2 cervical cancer, according to a recent study.

Contrary to popular belief, it is possible to have a healthy pregnancy alongside a breast cancer diagnosis, as long as treatment is monitored and administered correctly.

The coming of New Year’s Eve can make us feel panicky about our health resolutions.

Several trials testing vadastuximab talirine for use in patients with AML were recently halted, according to the drug's manufacturer.

The combination of onartuzumab and Avastin (bevacizumab) showed no additional benefit for patients with glioblastoma, according to a recent study.

Can having a sense of purpose in life help people live longer?

A breast cancer and melanoma survivor clears her household and cancer clutter.